Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Medical Research and Opinion
|
January 1, 1983
Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin
B Chattopadhyay, I Hall, S R Curnow
The Journal of Hospital Infection
|
June 1, 1981
Distribution of extraurinary beta-haemolytic streptococci in clinical specimens
B Chattopadhay, I Hall, S R Curnow
The Journal of Antimicrobial Chemotherapy
|
December 1, 1981
Ceftazidime (GR 20263), a new cephalosporin derivative with excellent activity against Pseudomonas and Enterobacteriaceae
B Chattopadhyay, I Hall, S R Curnow
The Journal of Antimicrobial Chemotherapy
|
February 1, 1983
Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins
B Chattopadhyay, I Hall, S R Curnow
Journal of Clinical Pathology
|
August 1, 1983
Faecal carriage rate of Aeromonas hydrophila
S E Millership, S R Curnow, B Chattopadhyay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Ondansetron: confusing documentation surrounding an extrapyramidal reaction
B B Kanarek, R Curnow, J Palmer, et al.
Pediatric Neurology
|
April 27, 2019
Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting as Isolated Psychosis in an Adolescent Female
Sarah R Curnow, Sally Chow, Eppie M Yiu, et al.
European Journal of Pharmacology
|
February 11, 1994
Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole
G R Dawson, R Curnow, P Bayley, et al.
Epilepsy Research
|
February 23, 2020
Focal cortical hypermetabolism in atypical benign rolandic epilepsy
Sarah R Curnow, Simon J Vogrin, Sarah Barton, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu
V Pullarkat, Y Deo, J Link, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Medical Research and Opinion
|
January 1, 1983
Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin
B Chattopadhyay, I Hall, S R Curnow
The Journal of Hospital Infection
|
June 1, 1981
Distribution of extraurinary beta-haemolytic streptococci in clinical specimens
B Chattopadhay, I Hall, S R Curnow
The Journal of Antimicrobial Chemotherapy
|
December 1, 1981
Ceftazidime (GR 20263), a new cephalosporin derivative with excellent activity against Pseudomonas and Enterobacteriaceae
B Chattopadhyay, I Hall, S R Curnow
The Journal of Antimicrobial Chemotherapy
|
February 1, 1983
Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins
B Chattopadhyay, I Hall, S R Curnow
Journal of Clinical Pathology
|
August 1, 1983
Faecal carriage rate of Aeromonas hydrophila
S E Millership, S R Curnow, B Chattopadhyay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1992
Ondansetron: confusing documentation surrounding an extrapyramidal reaction
B B Kanarek, R Curnow, J Palmer, et al.
Pediatric Neurology
|
April 27, 2019
Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting as Isolated Psychosis in an Adolescent Female
Sarah R Curnow, Sally Chow, Eppie M Yiu, et al.
European Journal of Pharmacology
|
February 11, 1994
Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole
G R Dawson, R Curnow, P Bayley, et al.
Epilepsy Research
|
February 23, 2020
Focal cortical hypermetabolism in atypical benign rolandic epilepsy
Sarah R Curnow, Simon J Vogrin, Sarah Barton, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu
V Pullarkat, Y Deo, J Link, et al.
Page
of 2